ArticleFrontiers in oncology2023

Serological and cellular response to mRNA-SARS-CoV2 vaccine in patients with hematological lymphoid malignancies: Results of the study "Cervax".

Sara Mohamed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.